MACROGENICS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
MACROGENICS, INC. (MGNX) had Deferred Tax Liabilities, Property, Plant and Equipment of $0 as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2023-03-15
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $0.00.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.69M.
- 2020-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $2.12M.
- 2019-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $438.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-15 |
| 2021-12-31 | $1.69M 10-K · filed 2023-03-15 |
| 2020-12-31 | $2.12M 10-K · filed 2022-02-24 |
| 2019-12-31 | $438.00K 10-K · filed 2021-02-25 |
| 2018-12-31 | $1.91M 10-K · filed 2020-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |